Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Leukemia × STA 9090 × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Fallopian Tube Neoplasms 2 Carcinoma, Ovarian Epithelial 2 Small Cell Lung Carcinoma 1 Sarcoma 1 Neurofibrosarcoma 1 Neoplasms 1 Lung Cancer - Malignant Pleural Mesothelioma 1 Leukemia, Myeloid, Acute 1 Leukemia 1 Disorders of Sex Development 1

Interventions

Cyclophosphamide 34 fludarabine phosphate 33 Cytarabine 33 fludarabine 26 Peripheral Blood Stem Cell Transplantation 23 Filgrastim 23 Methotrexate 18 Busulfan 17 Rituximab 15 Cyclosporine 14 Azacitidine 14 Melphalan 13 Clofarabine 13 Tacrolimus 12 venetoclax 11 Mycophenolic Acid 10 Etoposide 10 Alemtuzumab 10 Radiotherapy 9 Imatinib Mesylate 8 Granulocyte Colony-Stimulating Factor 8 Decitabine 8 ruxolitinib 7 Whole-Body Irradiation 7 Stem Cell Transplantation 7 Idarubicin 7 Dexamethasone 7 Antilymphocyte Serum 7 aldesleukin 6 Mitoxantrone 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01236144 2014-06-11

AML18 Pilot

Cardiff University

Phase 1/2 Completed

Other hematologic neoplasm

Leukemia, Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon ⚡